Research studies
| Study Name | Population | Protocol |
|---|---|---|
| ApcinteX/SerpinPC/AP-0102 PRESent2 | Haemophilia A & B, with and without inhibitors |
A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B |
| GT4BD | Newly referred patients with suspected inherited bleeding disorder |
|
| SeroCanAAV | Male participants 18 years or older, with mild, moderately severe to severe hemophilia B |
A Canada-Wide Hemophilia B Biobanking Initiative and an Independent Observational Study of AAV5 Neutralizing Antibody Seroprevalence and Seroconversion in the Canadian Hemophilia B Population |